-89.7%
RIVN vs THC
+232.6%
-322.3%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -8.5% | -0.2% | -8.4% | -8.5% |
| 7D | -15.2% | -8.0% | -7.2% | -13.2% |
| 30D | -17.1% | -2.2% | -14.9% | -16.6% |
| 3M | -35.5% | -3.5% | -32.0% | -35.0% |
| 6M | -24.8% | +40.4% | -65.2% | -33.0% |
| YTD | -47.6% | +32.4% | -80.0% | -53.1% |
| 1Y | -29.5% | +41.0% | -70.5% | -38.4% |
| 3Y | -39.0% | +305.2% | -344.2% | -67.2% |
| 5Y | -92.0% | +239.8% | -331.8% | -95.6% |
| All | -89.7% | +232.6% | -322.3% | -94.3% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling